Hématologie
Volume 14, issue 3, Juillet 2008
Introduction
Introduction
(p.3)
Pr Henri Rochant
Free Access
Séances spéciales
Hémoglobinurie paroxystique nocturne
(p.14-20)
Régis Peffault de Latour
Free Access
Actualités
Leucémies aiguës
(p.21-4)
Emmanuel Raffoux
Free Access
Myélome multiple, maladie de Waldenström et amylose
(p.25-9)
Laurent Pascal, Xavier Leleu
Free Access
Leucémie myéloïde chronique
(p.30-3)
François-Xavier Mahon
Free Access
Syndromes myélodysplasiques
(p.34-9)
Raphaël Itzykson, Pierre Fenaux
Free Access
Editorial
From functional screening to identification of therapeutics targets in multiple myeloma
(p.171)
François Sigaux
Free Access
Focus
AML1/RUNX1 is frequently altered in chronic myelogenous leukemia in blast crisis and is associated with trisomy 21
(p.173-6)
Catherine Roche-Lestienne, Lauréline Deluche, Sami Joha, Jean-Luc Laï, Selim Corm, Franck-Emmanuel Nicolini, Claude Preudhomme
Free Access
Compte rendu
Supportive therapy for low-risk myelodysplastic syndromes
(p.178-84)
Julie Gay
Free Access
New therapeutical perspectives for imatinib resistant and intolerant CML patients
(p.185-8)
Selim Corm
Free Access
Revue
Mesenchymal stem cells and immune modulation: place and potential side effects in cell therapy
(p.189-93)
Christine Dosquet, Marie Moreau
Free Access
Prognostic factors of monoclonal gammopathy of undetermined significance
(p.196-206)
Olivier Decaux, Hervé Avet-Loiseau, Bernard Grosbois
Free Access
The WHO revised diagnostic criteria for myeloprolative disorders
(p.208-15)
Jean Brière
Free Access
Mise au point
New insight in the pathophysiology of multiple myeloma bone lesions
(p.218-27)
Nicola Giuliani
Free Access
Bisphophonates in multiple myeloma
(p.239-43)
Philippe Moreau
Free Access
New guidelines for the use of bisphosphonates in multiple myeloma
(p.244-7)
Margaret Macro
Free Access